The past decade has witnessed a new surge in the development of complement-targeted therapeutics, fueled by the successful launch of first complement drugs and the discovery of both orphan and highly prevalent diseases with contribution of complement. Apart from offering new hope for patients suffering from such diseases, the study of complement pathways, mutations, and deficiencies also teaches us important lessons about the role of complement in health and disease and allows us to refine our models and tools for applied and basic research. This conference aims to bring together academic and industry scientists and clinical development experts who are focused on contemporary and emerging aspects of complement-mediated disease pathogenesis and the development of therapeutics that modulate this system in a beneficial manner. Topics discussed during the conference include: targets, mechanisms & delivery options; therapeutic approaches & pipeline compounds; infections, periodontal diseases & sepsis; autoimmune & blood disorders (e.g. lupus, PNH); inflammatory diseases (e.g. asthma, arthritis); ocular diseases (e.g. AMD); kidney diseases (e.g. aHUS, MPGN II); neurological diseases (e.g. Alzheimer’s); metabolic & cardiovascular diseases; organ/cell transplantation & I/R injury; biomaterials & drug delivery devices;  diagnostics & imaging.

Complement Therapeutics
(based on the topics discussed at the 5th Complement Therapeutics Conference)
Edited By: John D Lambris, Michael V Holers, Daniel Ricklin

Inflammation and Retinal Disease: Complement Biology and Pathology
(based on the topics discussed at the 2007 Conference on the role of complement in Inflammation and Retinal Disease)
Edited By: Lambris, John D.; Adamis, Anthony P. (Eds.)

Current Topics in Complement II
(based on the topics discussed at the 4th Complement Therapeutics Conference)
Edited By: John D. Lambris

Current Topics in Complement
(based on the topics discussed at the 3rd Complement Therapeutics Conference)
Edited By: John D. Lambris